The Influence of Short Motifs on the Anticancer Activity of HB43 Peptide. - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Pharmaceutics Année : 2022

The Influence of Short Motifs on the Anticancer Activity of HB43 Peptide.

(1) , , (2) , (3, 4) , (3, 4) , (2) , , , (5) , (5)
1
2
3
4
5

Résumé

Despite the remarkable similarity in amino acid composition, many anticancer peptides (ACPs) display significant differences in terms of activity. This strongly suggests that particular relative dispositions of amino acids (motifs) play a role in the interaction with their biological target, which is often the cell membrane. To better verify this hypothesis, we intentionally modify HB43, an ACP active against a wide variety of cancers. Sequence alignment of related ACPs by ADAPTABLE web server highlighted the conserved motifs that could be at the origin of the activity. In this study, we show that changing the order of amino acids in such motifs results in a significant loss of activity against colon and breast cancer cell lines. On the contrary, amino acid substitution in key motifs may reinforce or weaken the activity, even when the alteration does not perturb the amphipathicity of the helix formed by HB43 on liposomes mimicking their surface. NMR and MD simulations with different membrane models (micelles, bicelles, and vesicles) indicate that the activity reflects the insertion capability in cancer-mimicking serine-exposing membranes, supported by the insertion of N-terminal phenylalanine in the FAK motif and the anchoring to the carboxylate of phosphatidylserine by means of arginine side chains.

Dates et versions

hal-03686658 , version 1 (02-06-2022)

Identifiants

Citer

Claudia Herrera-León, Francisco Ramos-Martin, Hassan El Btaouri, Viviane Antonietti, Pascal Sonnet, et al.. The Influence of Short Motifs on the Anticancer Activity of HB43 Peptide.. Pharmaceutics, 2022, 14 (5), ⟨10.3390/pharmaceutics14051089⟩. ⟨hal-03686658⟩
11 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More